(MedPage Today) — An investigational yellow fever vaccine (vYF) that could help avoid shortages matched the immunogenicity and safety profile of the FDA-approved shot (YF-VAX), according to a phase II trial.
In healthy adults with no history…
Source link
Ad Banner
Show Comments (0)
Hide Comments (0)
Subscribe
Login
0 Comments
Oldest
